Context Capital Management »

Travere Therapeutics shares owned by Context Capital Management

Quarter-by-quarter ownership of Travere Therapeutics shares owned by Context Capital Management from 13F filings

Historical chart of Context Capital Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Context Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Context Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $60M 51M 1.18

More positions owned by Context Capital Management

Ishares Bitcoin Trust Etf Shs Ben Int Put Option (IBIT)
Echostar Corp Note 3.875%11/3 (Principal)
Makemytrip Limited Mauritius Note 7/0 (Principal)
Gamestop Corp Note 4/0 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)
Enovis Corporation Note 3.875%10/1 (Principal)
Mara Holdings Note 3/0 (Principal)
Peloton Interactive Note 5.500%12/0 (Principal)
Gamestop Corp Note 6/1 (Principal)
Teladoc Health Note 1.250% 6/0 (Principal)
Strategy Note 12/0 (Principal)
Rivian Automotive Note 4.625% 3/1 (Principal)
Alphabet Dep Shs Rp1/20 A
Snap Note 0.500% 5/0 (Principal)
Applied Digital Corp Note 2.750% 6/0 (Principal)

View all positions for Context Capital Management

Top funds holding Travere Therapeutics

Context Capital Management
Calamos Advisors
RWC Asset Management
Calamos Wealth Management
Rsm Us Wealth Management

View all funds holding Travere Therapeutics